Hepatobiliary Disease Platform
The hepatobiliary system (comprised of the liver, gallbladder, and bile ducts) plays an important role in digestion and in the biotransformation and disposition of endogenous molecules and drugs. Hepatobiliary diseases range from minor infection or scarring to serious conditions such as cancer. At this year’s EASL conference, WuXi AppTec showcased our comprehensive platform of hepatobiliary-related services, such as our CAP-certified pathology laboratory and our extensive panel of animal disease models, including NAFLD, fibrosis, cirrhosis, and a clinically relevant NASH mouse model.
Hepatobiliary Disease Platform
- All-encompassing hepatobiliary disease models:
- NAFLD, NASH, Fibrosis, Cirrhosis, PBC/PSC, ALD, and more
- Comprehensive hepatic tissue bank and transcriptomics database
- Professional quantitative analysis in pathology
Histopathology Laboratory
- CAP-certified pathology laboratory
- Tissue processor
- Embedding center
- Cyostats
- Microtomes
- Staining workstation
- IHC & ISH stainer
- Laser-scanning confocal microscope
- HALO-AI quantitative histopathology
Hepatobiliary_Disease Platform
Related Content
KRAS G12D inhibitors continue to advance, but treatment resistance remains an important challenge. Understanding how that resistance develops is critical...
VIEW RESOURCEMetabolic dysfunction-associated steatohepatitis (MASH) remains a significant global health challenge, driven by a complex interplay of lipid dysregulation, inflammation, and...
VIEW RESOURCE